Empegfilgrastim is under investigation in clinical trial NCT01569087 (Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.